Clinical trial

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

NCT00539071

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-03-01

PhasePHASE4

Study timeline

Study start (actual)2008-03-01Date precision: month

Registry last updated2025-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Interventions

long-acting injectable risperidoneDRUG

long acting injectable risperidone, Conventional Dose GroupDRUG

long acting injectable risperidone, High Dose GroupDRUG

Sponsors & collaborators

Northwestern Universitylead sponsor

Ortho-McNeil Janssen Scientific Affairs, LLCcollaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00539071 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.